Total Payments
$103,172
2024 Payments
$24.21
Companies
28
Transactions
129
Medicare Patients
913
Medicare Billing
$122,624
Payment Breakdown by Category
Other$99,520 (96.5%)
Food & Beverage$2,470 (2.4%)
Consulting$1,125 (1.1%)
Education$56.99 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Grant | $97,720 | 4 | 94.7% |
| Food and Beverage | $2,470 | 121 | 2.4% |
| Honoraria | $1,800 | 2 | 1.7% |
| Consulting Fee | $1,125 | 1 | 1.1% |
| Education | $56.99 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $96,124 | 7 | $0 (2022) |
| ABBVIE INC. | $2,415 | 42 | $0 (2022) |
| Mahana Therapeutics, Inc. | $2,001 | 3 | $0 (2022) |
| GI Supply, Inc. | $1,050 | 1 | $0 (2021) |
| Janssen Scientific Affairs, LLC | $196.17 | 2 | $0 (2021) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $187.25 | 11 | $0 (2022) |
| Janssen Biotech, Inc. | $160.42 | 6 | $0 (2022) |
| Takeda Pharmaceuticals U.S.A., Inc. | $134.90 | 9 | $0 (2022) |
| Celgene Corporation | $128.70 | 12 | $0 (2022) |
| Aries Pharmaceuticals, Inc. | $100.45 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $24.21 | 1 | GENZYME CORPORATION ($24.21) |
| 2023 | $46.10 | 2 | Merck Sharp & Dohme LLC ($30.16) |
| 2022 | $3,090 | 65 | Mahana Therapeutics, Inc. ($2,001) |
| 2021 | $1,197 | 3 | GI Supply, Inc. ($1,050) |
| 2019 | $96,258 | 11 | PFIZER INC. ($96,054) |
| 2018 | $2,115 | 27 | AbbVie, Inc. ($1,835) |
| 2017 | $442.35 | 20 | Prometheus Laboratories Inc. ($95.92) |
All Payment Transactions
129 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $24.21 | General |
| Category: Immunology | ||||||
| 08/25/2023 | RedHill Biopharma Inc. | Talicia (Drug) | Food and Beverage | In-kind items and services | $15.94 | General |
| Category: Antibiotic | ||||||
| 04/26/2023 | Merck Sharp & Dohme LLC | DIFICID (Drug) | Food and Beverage | In-kind items and services | $30.16 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 12/07/2022 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $21.85 | General |
| Category: Neuroscience | ||||||
| 11/15/2022 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $25.44 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/07/2022 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $29.21 | General |
| Category: VIROLOGY | ||||||
| 11/07/2022 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $9.28 | General |
| Category: IMMUNOLOGY | ||||||
| 11/01/2022 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $21.85 | General |
| Category: Neuroscience | ||||||
| 10/17/2022 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $15.88 | General |
| 10/14/2022 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $14.84 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/12/2022 | Braintree Laboratories, Inc. | SUTAB (Drug) | Food and Beverage | In-kind items and services | $18.13 | General |
| Category: GI COLON PREP | ||||||
| 10/05/2022 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $17.34 | General |
| Category: IMMUNOLOGY | ||||||
| 09/19/2022 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $15.27 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/15/2022 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $20.77 | General |
| Category: Immunology | ||||||
| 09/15/2022 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $13.35 | General |
| Category: IMMUNOLOGY | ||||||
| 09/08/2022 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $19.46 | General |
| Category: ENDOCRINOLOGY | ||||||
| 09/02/2022 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $5.00 | General |
| Category: IMMUNOLOGY | ||||||
| 09/01/2022 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $10.82 | General |
| Category: Neuroscience | ||||||
| 08/31/2022 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $14.10 | General |
| Category: IMMUNOLOGY | ||||||
| 08/25/2022 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $12.05 | General |
| Category: IMMUNOLOGY | ||||||
| 08/18/2022 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $14.46 | General |
| Category: IMMUNOLOGY | ||||||
| 08/15/2022 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $17.51 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 08/10/2022 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $22.38 | General |
| Category: Immunology | ||||||
| 08/05/2022 | Janssen Biotech, Inc. | REMICADE (Biological), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $27.54 | General |
| Category: Immunology | ||||||
| 08/02/2022 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $14.10 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 342 | 597 | $252,945 | $46,771 |
| 2022 | 10 | 432 | 788 | $326,635 | $58,803 |
| 2021 | 8 | 139 | 169 | $74,011 | $17,050 |
Total Patients
913
Total Services
1,554
Medicare Billing
$122,624
Procedure Codes
28
All Medicare Procedures & Services
28 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 61 | 112 | $33,578 | $10,968 | 32.7% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 50 | 50 | $55,083 | $10,051 | 18.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 50 | 50 | $18,015 | $5,989 | 33.2% |
| 88312 | Special stained specimen slides to identify organisms including interpretation and report | Office | 2023 | 16 | 70 | $21,046 | $4,626 | 22.0% |
| 88313 | Special stained specimen slides to examine tissue including interpretation and report | Office | 2023 | 17 | 69 | $25,530 | $3,693 | 14.5% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2023 | 32 | 129 | $16,987 | $3,433 | 20.2% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 43 | 44 | $32,195 | $3,358 | 10.4% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 33 | 33 | $30,767 | $2,485 | 8.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 29 | 29 | $7,204 | $2,028 | 28.2% |
| 45381 | Injection beneath lining of large bowel using a flexible endoscope | Facility | 2023 | 11 | 11 | $12,540 | $139.62 | 1.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 79 | 141 | $39,665 | $13,876 | 35.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 80 | 80 | $37,200 | $9,297 | 25.0% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 49 | 49 | $54,194 | $9,213 | 17.0% |
| 88312 | Special stained specimen slides to identify organisms including interpretation and report | Office | 2022 | 24 | 95 | $31,635 | $6,397 | 20.2% |
| 88313 | Special stained specimen slides to examine tissue including interpretation and report | Office | 2022 | 24 | 97 | $22,504 | $5,197 | 23.1% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2022 | 45 | 194 | $48,306 | $5,117 | 10.6% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 54 | 55 | $45,650 | $3,686 | 8.1% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 43 | 43 | $40,033 | $3,636 | 9.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 20 | 20 | $3,640 | $1,423 | 39.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 14 | 14 | $3,808 | $962.42 | 25.3% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 20 | 31 | $15,128 | $4,571 | 30.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 21 | 25 | $8,725 | $2,492 | 28.6% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 20 | 20 | $9,020 | $2,440 | 27.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 22 | 35 | $6,650 | $2,063 | 31.0% |
| 45380 | Biopsy of the large bowel using an endoscope (colonoscopy) | Facility | 2021 | 15 | 15 | $14,505 | $1,887 | 13.0% |
About Dr. Jordan Shapiro, MD
Dr. Jordan Shapiro, MD is a Gastroenterology healthcare provider based in Houston, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/13/2010. The National Provider Identifier (NPI) number assigned to this provider is 1073839239.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jordan Shapiro, MD has received a total of $103,172 in payments from pharmaceutical and medical device companies, with $24.21 received in 2024. These payments were reported across 129 transactions from 28 companies. The most common payment nature is "Grant" ($97,720).
As a Medicare-enrolled provider, Shapiro has provided services to 913 Medicare beneficiaries, totaling 1,554 services with total Medicare billing of $122,624. Data is available for 3 years (2021–2023), covering 28 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Houston, TX
- Active Since 04/13/2010
- Last Updated 01/15/2026
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1073839239
Products in Payments
- STELARA (Biological) $250.98
- CREON (Drug) $216.16
- Humira (Biological) $191.37
- ZEPOSIA (Drug) $128.70
- XIFAXAN (Drug) $128.45
- Entyvio (Biological) $106.81
- REMICADE (Biological) $105.61
- ELEVIEW (Device) $100.45
- HUMIRA (Biological) $93.18
- GATTEX (Drug) $89.64
- SKYRIZI (Biological) $87.63
- RINVOQ (Biological) $84.48
- DUPIXENT (Biological) $70.42
- DIFICID (Drug) $54.30
- MAVYRET (Drug) $52.92
- RELISTOR (Drug) $44.15
- SUCRAID (Drug) $43.90
- INFLECTRA (Biological) $38.49
- ENTYVIO (Biological) $38.37
- BREATHTEK (Device) $37.26
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Houston
Dr. Bincy Abraham, Md, MD
Gastroenterology — Payments: $1.9M
Gastroenterology $1.9M
Dr. Isaac Raijman, Md, MD
Gastroenterology — Payments: $1.6M
Gastroenterology $1.6M
Dr. Brooks Cash, Md, MD
Gastroenterology — Payments: $1.3M
Gastroenterology $1.3M
Dr. Mazen Noureddin, M.d, M.D
Gastroenterology — Payments: $786,099
Gastroenterology $786,099
Dr. Jason Hou, M.d, M.D
Gastroenterology — Payments: $372,514
Gastroenterology $372,514
Kalpesh Patel, Md, MD
Gastroenterology — Payments: $313,187
Gastroenterology $313,187